A launch won't wait for your data to be perfect. We stand up the leading indicators, targeting, and uptake tracking that keep a launch on plan — and tell you early when it isn't.
Built for commercial teams at Telix, Azurity, Alkermes, and UCB.
Pharma launch analytics tracks whether a new brand is landing — readiness before launch, leading indicators like NBRx in the first weeks, and uptake versus plan as it unfolds. Done right, it flags a shortfall while there's still time to act, not in the quarterly review.
Windows are short and every week counts. If the leading indicators aren't wired up, you're flying on lagging TRx and anecdotes — and by the time the trend is obvious, the launch curve is already set.
The window is short.
The signals are early.
By the time TRx confirms it, the moment to act has passed.
New-to-brand is the first real read that a launch is landing with new patients.
Actual demand against the launch curve you funded — ahead, on, or behind.
How many HCPs are writing, and how much — the shape beneath the number.
Actuals tracked against the launch curve, week by week. When the line diverges from plan, you see it early enough to shift targeting, message, or field effort — while it still matters.
The point isn't a prettier chart. It's the week you catch a shortfall instead of the quarter.
Readiness, in-flight tracking, and the decision each triggers — one connected system. The technology stays backstage; the launch curve is the headline.
See the early signals, decide where to shift, act on targeting and field effort, and Track uptake against plan every week.
You get the signals that matter early and a firm that knows which ones actually predict a launch — and which are noise. Speed to insight is the whole game at launch.
Launch analytics is two jobs that share a spine — and we build both.
Before day one: the data connected, the targets set, the plan instrumented so you can measure against it. Readiness is the difference between launching with a dashboard and launching with a hope.
After day one: NBRx, depth, and breadth against plan, refreshed weekly, so a shortfall is a signal you act on — not a surprise you explain later.
Every row ties to a launch decision a commercial lead actually makes — and how we get there.
| Decision | The question a leader asks | What you get | How we get there |
|---|---|---|---|
| Readiness | Are we instrumented to measure this launch? | A launch-ready data & targeting setup | Connected feeds, alignment, plan baseline |
| Early read | Is it landing with new patients? | NBRx leading-indicator tracking | Specialty pharmacy & claims signals |
| On plan? | Are we ahead or behind the curve? | Uptake-vs-plan views, weekly | Predictive models on your data |
| Where to push | Which segments & geographies to shift to? | Launch-time targeting | Prescriber & geo analytics |
Bundled, this becomes part of PharmaIQ — our commercial intelligence layer for specialty pharma.
A classification model predicting HCP prescribing behavior sharpened launch-time targeting — improving engagement efficiency by 35% and returning measurable ROI within five months.
Read the case study →“Before Rower, our commercial, marketing, and sales teams each worked from their own version of the data. Rower connected all three into one trusted version. We stopped debating the data and started making decisions with it.”
The questions we hear most from launch, brand, and commercial-ops leaders.
It's the analytics that tell you whether a new brand is landing — readiness before launch, leading indicators like NBRx in the first weeks, and uptake against the plan you funded. The goal is to catch a shortfall early enough to act on it.
NBRx (new-to-brand) is the cleanest early read that new patients are starting, followed by depth and breadth of prescribing — how many HCPs are writing and how much. TRx confirms the trend later, but by then the curve is largely set.
Readiness is the pre-launch work: data connected, targets set, plan instrumented. Uptake tracking is the in-flight work: measuring actuals against plan weekly. One prepares you to measure; the other tells you what the measurement means in time to act.
Yes. We start with the leading indicator that matters most and the data you already have, then extend. Waiting for perfect data is how launches end up measured only in hindsight.
Weeks. We prioritize the single view that tells you whether the launch is landing, wire up the specialty-pharmacy and claims signals behind it, and get it in leaders' hands early — then broaden.
One conversation. We'll tell you what it would take to launch with leading indicators, not hindsight.
We'll tell you what it would take to keep your launch on plan.
Book a diagnostic callAccessibility Statement
At Rower Consulting, we are committed to ensuring digital accessibility for everyone, including individuals with disabilities. We strive to continually improve the user experience for all visitors and apply the relevant accessibility standards of WCAG 2.1 (Web Content Accessibility Guidelines).
If you encounter any accessibility barriers or have suggestions for improving our website’s accessibility, please contact us through our Contact Form and we will work to address the issue.
Privacy Policy
Welcome to Rower Consulting (“we,” “our,” or “us”). We are committed to protecting your personal information and your right to privacy. This Privacy Policy explains how we collect, use, disclose, and safeguard your information when you visit our website https://rowerconsulting.com (the “Site”).
Please read this privacy policy carefully. If you do not agree with the terms of this privacy policy, please do not access the site.
We collect information in two ways:
We use the information we collect for the following purposes:
We use Google Site Kit to help us understand how visitors interact with our website and to improve our services. Google Site Kit integrates several Google services, which may include:
These services collect non-personally identifiable information which may include:
This information helps us to improve our website and its content. Google’s ability to use and share information collected by Google Site Kit is restricted by the Google Site Kit Terms of Service and the Google Privacy Policy. You can learn more about how Google uses data when you use our site by visiting https://www.google.com/policies/privacy/partners/.
We are committed to ensuring that your information is secure. We have implemented suitable physical, electronic, and managerial procedures to safeguard and secure the information we collect online to prevent unauthorized access or disclosure.
We do not sell or lease your personal information to any third parties. However, aggregated, anonymized data collected through Google Site Kit may be shared with Google as part of the service’s functionality.
We use cookies to improve your experience on our website. These cookies may collect non-personal information. You can choose to accept or decline cookies. Most web browsers automatically accept cookies, but you can usually modify your browser setting to decline cookies if you prefer.
Google Site Kit may use cookies to collect information. You can learn more about how Google uses cookies by visiting https://www.google.com/policies/privacy/partners/.
Depending on your location, you may have certain rights regarding your personal information, such as the right to access, correct, or delete your data. Please contact us if you wish to exercise these rights.
We may update our Privacy Policy from time to time. We will notify you of any changes by posting the new Privacy Policy on this page.
If you have any questions about this Privacy Policy, please contact us.
